Ligand Pharmaceuticals

LGND | NASDAQ

Price Alert Chart Builder DCF Calculator

$291.24

+$1.17 (+0.40%)

Sep 22, 2026, 10:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	290.54M	274.48M	268.09M	251.23M	187.58M	181.49M	167.13M	152.42M	133.48M	118.31M	131.31M	130.26M	156.61M	180.37M	172.91M	218.34M	223.95M	258.5M	277.13M	274.65M	251.66M	208.41M
Cost of Revenue	906.5K	3.81M	6.59M	35.41M	23.09M	4.86M	11.07M	9.9M	891K	17.89M	10.54M	30.49M	41.15M	51.85M	52.83M	43.2M	40.49M	58.72M	62.18M	61.93M	56.84M	33.89M
Gross Profit	289.64M	270.66M	261.5M	215.82M	164.5M	176.63M	156.06M	142.52M	132.59M	100.43M	120.78M	99.77M	115.46M	128.53M	120.08M	175.14M	183.46M	199.78M	214.96M	212.72M	194.83M	174.52M
Operating Income	100.93M	100.78M	47.2M	17.52M	-34.27M	-61.81M	-22.61M	-16.33M	-16.39M	725K	11.94M	27.48M	36.74M	47.38M	35.31M	35.87M	39.24M	76.31M	78.89M	77.37M	65.41M	26.77M
Interest Income	16.01M	17.63M	12.75M	8.29M	6.67M	7.81M	8.06M	7.82M	8.73M	8.3M	7.71M	7.04M	5.37M	3.35M	2.05M	1.21M	789K	724K	886K	1.09M	1.91M	3.64M
Pretax Income	237.96M	184.88M	158.96M	62.98M	-84.5M	-161.11M	2.52M	58.82M	53.01M	121.57M	63.66M	102.49M	126.99M	132.48M	67.8M	4.85M	7.75M	32.39M	47.3M	57.69M	30.82M	25.64M
Net Income	197.22M	153.56M	124.45M	48.58M	-75.86M	-132.62M	-4.03M	45.24M	42.14M	96.34M	52.15M	16.48M	27.16M	23.97M	-33.36M	-21.29M	-7.97M	23.65M	57.14M	68.32M	47.89M	39.25M
Selling & General & Admin	103.43M	94.48M	92.45M	93.03M	89.06M	86.5M	78.65M	69.04M	59.22M	52.89M	52.79M	56.65M	56.91M	57.71M	58.78M	56.67M	54.47M	57.09M	57.78M	70.13M	72.43M	67.79M
Research & Development	41.35M	33.25M	81.18M	82.1M	66.75M	65.54M	21.43M	22.49M	22.35M	23.85M	24.54M	-6.33M	-2.62M	-1.01M	1.51M	45.13M	52.83M	60.31M	69.01M	72.69M	68.6M	65.38M
Other Expenses	43.93M	42.15M	40.67M	23.18M	42.95M	86.4M	78.59M	67.32M	67.41M	22.97M	31.51M	21.98M	24.43M	24.44M	24.48M	37.47M	36.93M	6.06M	9.27M	-7.47M	-11.62M	14.58M
Operating Expenses	188.71M	169.88M	214.3M	198.3M	198.76M	238.44M	178.67M	158.85M	148.98M	99.7M	108.84M	72.3M	78.72M	81.14M	84.77M	139.27M	144.23M	123.47M	136.06M	135.35M	129.41M	147.75M
Interest Expense	3.53M	4.69M	3.81M	2.9M	3.64M	3.76M	3.03M	2.28M	1.54M	557K	656K	765K	1.1M	1.25M	1.8M	6.03M	10.14M	14.58M	19.63M	21.54M	23.37M	24.7M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	189.61M	173.69M	220.89M	233.71M	221.85M	243.3M	189.74M	168.75M	149.87M	117.59M	119.37M	102.78M	119.87M	132.99M	137.6M	182.47M	184.72M	182.19M	198.24M	197.28M	186.25M	181.64M
Income Tax Expense	40.74M	31.32M	34.51M	14.4M	-8.63M	-28.49M	6.55M	13.57M	10.87M	25.23M	9.84M	56.21M	60.79M	55.97M	47.83M	946K	-227K	6.29M	-9.84M	-10.62M	-17.07M	-13.61M
Shares Outstanding (Basic)	20.06M	19.88M	19.73M	19.37M	19.33M	19.19M	18.97M	18.42M	18.03M	17.73M	17.47M	17.38M	17.28M	17.06M	16.89M	16.89M	16.87M	16.82M	16.73M	16.69M	16.66M	16.44M
Shares Outstanding (Diluted)	21.84M	19.88M	21.14M	20.17M	19.93M	19.19M	18.97M	18.42M	18.03M	18.12M	17.68M	17.38M	17.73M	17.97M	16.89M	17.13M	16.87M	16.82M	16.73M	17.14M	17.17M	17.25M
EPS (Basic)	10.01	7.84	6.30	2.39	-3.99	-7.12	-0.05	2.63	2.28	5.29	2.89	0.81	1.57	1.39	-1.98	-1.24	-0.44	1.45	3.46	4.12	2.88	2.42
EPS (Diluted)	9.35	7.37	5.83	2.07	-4	-7.12	-0.16	2.51	2.16	5.17	2.75	0.68	1.44	1.26	-1.98	-1.24	-0.46	1.38	3.34	3.99	2.77	2.30
EBITDA	273.74M	222.24M	195.99M	99.9M	-45.94M	-122.11M	40.79M	96.63M	89.7M	157.92M	100.91M	142.07M	171.79M	181.02M	120.97M	64.06M	62.39M	64.13M	83.53M	95.71M	70.4M	85.02M
EBIT	239.71M	187.78M	160.98M	65.88M	-80.85M	-157.35M	5.55M	61.1M	54.55M	122.13M	64.32M	103.26M	128.09M	133.73M	69.6M	10.88M	10.1M	12.64M	32.59M	44.9M	27.65M	50.34M
Depreciation & Amortization	34.03M	34.46M	35.01M	34.01M	34.91M	35.24M	35.24M	35.53M	35.15M	35.79M	36.59M	38.81M	43.7M	47.29M	51.37M	53.18M	52.29M	51.5M	50.95M	50.81M	42.75M	34.68M